ZA912695B - Monoclonal anti-igm antibodies,their production and use,and hybridomas for producing the same - Google Patents

Monoclonal anti-igm antibodies,their production and use,and hybridomas for producing the same

Info

Publication number
ZA912695B
ZA912695B ZA912695A ZA912695A ZA912695B ZA 912695 B ZA912695 B ZA 912695B ZA 912695 A ZA912695 A ZA 912695A ZA 912695 A ZA912695 A ZA 912695A ZA 912695 B ZA912695 B ZA 912695B
Authority
ZA
South Africa
Prior art keywords
hybridomas
producing
production
same
monoclonal anti
Prior art date
Application number
ZA912695A
Inventor
Michael G Rosenblum
G Rosenblum Michael
Nicholas J Donato
J Donato Nicholas
Original Assignee
Res Dev Foundation
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Res Dev Foundation filed Critical Res Dev Foundation
Publication of ZA912695B publication Critical patent/ZA912695B/en

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
    • C07K16/42—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against immunoglobulins
    • C07K16/4283—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against immunoglobulins against an allotypic or isotypic determinant on Ig
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/50—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates
    • A61K47/51—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent
    • A61K47/68—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent the modifying agent being an antibody, an immunoglobulin or a fragment thereof, e.g. an Fc-fragment
    • A61K47/6835—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent the modifying agent being an antibody, an immunoglobulin or a fragment thereof, e.g. an Fc-fragment the modifying agent being an antibody or an immunoglobulin bearing at least one antigen-binding site
    • A61K47/6873—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent the modifying agent being an antibody, an immunoglobulin or a fragment thereof, e.g. an Fc-fragment the modifying agent being an antibody or an immunoglobulin bearing at least one antigen-binding site the antibody targeting an immunoglobulin; the antibody being an anti-idiotypic antibody
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Immunology (AREA)
  • General Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Organic Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Biophysics (AREA)
  • Animal Behavior & Ethology (AREA)
  • Engineering & Computer Science (AREA)
  • Public Health (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biochemistry (AREA)
  • Epidemiology (AREA)
  • Genetics & Genomics (AREA)
  • Molecular Biology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
ZA912695A 1990-04-27 1991-04-11 Monoclonal anti-igm antibodies,their production and use,and hybridomas for producing the same ZA912695B (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US51597490A 1990-04-27 1990-04-27

Publications (1)

Publication Number Publication Date
ZA912695B true ZA912695B (en) 1993-02-24

Family

ID=24053580

Family Applications (1)

Application Number Title Priority Date Filing Date
ZA912695A ZA912695B (en) 1990-04-27 1991-04-11 Monoclonal anti-igm antibodies,their production and use,and hybridomas for producing the same

Country Status (12)

Country Link
EP (1) EP0538267A4 (en)
JP (1) JPH06504424A (en)
CN (1) CN1057072A (en)
CA (1) CA2079901A1 (en)
IE (1) IE911172A1 (en)
IL (1) IL97827A0 (en)
NZ (1) NZ237784A (en)
PT (1) PT97482B (en)
RU (1) RU2105062C1 (en)
TW (1) TW349995B (en)
WO (1) WO1991017257A1 (en)
ZA (1) ZA912695B (en)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
BRPI0918791A2 (en) 2008-09-05 2016-10-25 Sekisui Medical Co Ltd anti-human IgM monoclonal antibody, functional fragment, immunoagglutination test, immunoagglutination test reagent and immunoagglutination test kit, hybridoma, method of producing an anti-human IgM monoclonal antibody agent, immunotest, and immunotest reagent and immunotest kit
CN108384761B (en) * 2018-03-30 2020-08-11 四川迈克生物新材料技术有限公司 Anti-human IgM monoclonal antibody, hybridoma cell strain and application thereof
WO2023088443A1 (en) * 2021-11-20 2023-05-25 东莞市朋志生物科技有限公司 Anti-human igm antibody and preparation method therefor and use thereof

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4792447A (en) * 1981-07-23 1988-12-20 Board Of Regents, The University Of Texas System Anti-immunoglobulin toxin conjugates useful in the treatment of B cell tumors
AU9016591A (en) * 1990-10-25 1992-05-26 Tanox Biosystems, Inc. Glycoproteins associated with membrane-bound immunoglobulins as antibody targets on B cells

Also Published As

Publication number Publication date
CA2079901A1 (en) 1991-10-28
EP0538267A1 (en) 1993-04-28
IL97827A0 (en) 1992-06-21
PT97482B (en) 1998-08-31
NZ237784A (en) 1992-09-25
CN1057072A (en) 1991-12-18
IE911172A1 (en) 1991-11-06
PT97482A (en) 1992-01-31
TW349995B (en) 1999-01-11
AU650659B2 (en) 1994-06-30
AU7866491A (en) 1991-11-27
WO1991017257A1 (en) 1991-11-14
RU2105062C1 (en) 1998-02-20
JPH06504424A (en) 1994-05-26
EP0538267A4 (en) 1994-06-01

Similar Documents

Publication Publication Date Title
EP0539970A3 (en) Methods for producing human lymphocytes and human monoclonal antibodies, and human monoclonal antibodies produced thereby
IL88145A0 (en) Monoclonal antibodies against human interleukin-4 and hybridomas producing the same
GB8910395D0 (en) Human monoclonal antibody and hybridoma producing the same
EP0578515A3 (en) Humanized monoclonal antibodies.
EP0580859A4 (en) Anti-eda monoclonal antibody
AU2712192A (en) Monoclonal antibodies against mycoplasma pneumoniae, hybridomas producing these, methods for the preparation thereof, and the use thereof
IL90017A0 (en) Monoclonal antibodies
ZA898777B (en) Monoclonal antibodies
GB9204928D0 (en) Monoclonal antibody production
EP0506523A3 (en) Monoclonal antibodies
ZA898499B (en) Anti-fucosylcermiade monoclonal antibody
ZA912695B (en) Monoclonal anti-igm antibodies,their production and use,and hybridomas for producing the same
EP0554458A4 (en) Immunoassay, monoclonal antibody and hybridoma
IL91649A0 (en) Hybrid monoclonal antibodies,their production and use
ZA89258B (en) Monoclonal antibodies
GB8927389D0 (en) Monoclonal antibodies
GB8820036D0 (en) Monoclonal antibodies
EP0667395A4 (en) Monoclonal antibody, process for producing the same, and use thereof.
ZA912136B (en) Anti-oncostatin m monoclonal antibodies
EP0446763A3 (en) Antigen for producing anti-idiotype antibody, anti-idiotype antibody and method for producing the anti-idiotype antibody
IE901956L (en) Monoclonal antibody.
IE900922L (en) Monoclonal antibody
IE901210L (en) Monoclonal antibody
IE900593L (en) Monoclonal antibodies
ZA897023B (en) Hybrid monoclonal antibodies,their production and use